Randomized Controlled Trial
Copyright ©The Author(s) 2025.
World J Hepatol. Jan 27, 2025; 17(1): 101704
Published online Jan 27, 2025. doi: 10.4254/wjh.v17.i1.101704
Figure 1
Figure 1  Flow diagram of the study.
Figure 2
Figure 2 Mean controlled attenuation parameter at baseline and weeks 12 and 24 in the intervention and control groups with metabolic dysfunction-associated steatotic liver disease. P values are from repeated measures analysis of variance. CAP: Controlled attenuation parameter. Group A: Silybum marianum and alpha-lipoic acid + Mediterranean diet; Group B: Placebo + Mediterranean diet.